These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10340908)

  • 21. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
    Sidle A; Palaty C; Dirks P; Wiggan O; Kiess M; Gill RM; Wong AK; Hamel PA
    Crit Rev Biochem Mol Biol; 1996 Jun; 31(3):237-71. PubMed ID: 8817077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; Atienza C; Stilwell A; McMasters KM
    Clin Cancer Res; 1999 Aug; 5(8):2242-50. PubMed ID: 10473112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Balancing proliferation and apoptosis in vivo: the Goldilocks theory of E2F/DP action.
    Yamasaki L
    Biochim Biophys Acta; 1999 Mar; 1423(2):M9-15. PubMed ID: 10214348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple members of the E2F transcription factor family are the products of oncogenes.
    Xu G; Livingston DM; Krek W
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1357-61. PubMed ID: 7877982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of cell-cycle-regulating transcription factor E2F-1 in colorectal carcinomas.
    Yasui W; Fujimoto J; Suzuki T; Ono S; Naka K; Yokozaki H; Tahara E
    Pathobiology; 1999; 67(4):174-9. PubMed ID: 10738178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
    Halaban R; Cheng E; Smicun Y; Germino J
    J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
    Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
    Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.
    Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B
    J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.
    Esrig D; Spruck CH; Nichols PW; Chaiwun B; Steven K; Groshen S; Chen SC; Skinner DG; Jones PA; Cote RJ
    Am J Pathol; 1993 Nov; 143(5):1389-97. PubMed ID: 7901994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor induction and tissue atrophy in mice lacking E2F-1.
    Yamasaki L; Jacks T; Bronson R; Goillot E; Harlow E; Dyson NJ
    Cell; 1996 May; 85(4):537-48. PubMed ID: 8653789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas.
    Zacharatos P; Kotsinas A; Evangelou K; Karakaidos P; Vassiliou LV; Rezaei N; Kyroudi A; Kittas C; Patsouris E; Papavassiliou AG; Gorgoulis VG
    J Pathol; 2004 Jul; 203(3):744-53. PubMed ID: 15221933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.
    de la Luna S; Allen KE; Mason SL; La Thangue NB
    EMBO J; 1999 Jan; 18(1):212-28. PubMed ID: 9878064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique roles for E2F1 in the mouse lens in the absence of functional pRB proteins.
    Hyde RK; Griep AE
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1509-16. PubMed ID: 11980867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
    Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
    Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
    Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
    Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F.
    Ormondroyd E; de la Luna S; La Thangue NB
    Oncogene; 1995 Oct; 11(8):1437-46. PubMed ID: 7478568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.